Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trialRobin Kate Kelley, Ming‐Huang Chen, Abby B. Siegel et al.|The Lancet|2023Cited by 1k
Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic CholangiocarcinomaLipika Goyal, John Bridgewater, Funda Meric‐Bernstam et al.|New England Journal of Medicine|2023Cited by 530
Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: Current advancements and future perspectivesB. Ten Haaft, Ángela Lamarca, Manuel Pedregal et al.|European Journal of Cancer|2024Cited by 50
Hepatic arterial infusion pump chemotherapy in patients with advanced intrahepatic cholangiocarcinoma confined to the liver: A multicenter phase II trial.Stijn Franssen, Bas Groot Koerkamp, Merve Rousian et al.|Journal of Clinical Oncology|2024Cited by 12
Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational studyLenka N.C. Boyd, Heinz‐Josef Klümpen|Frontiers in Pharmacology|2023Cited by 9